Autonomix Medical, Inc. Common Stock
AMIXNASDAQHealthcare● Active
$0.40
$-0.01(-1.90%)
Market Cap$2069800
P/E Ratio—
52W High$2.64
52W Low$0.2
Autonomix Medical, Inc. Common Stock (AMIX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMIX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Jun 4, 2026EPS Actual
-$0.23
Est. -$0.23 · +0.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Jun 4, 2026
After Market Close
✓ 3-Quarter EPS Beat Streak
AMIX reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.30 | — | — | — | — | — |
| — Q2 FY2026 | Jun 4, 2026 | -$0.23 | -$0.23 | +0.0% | — | — | — |
| — Q1 FY2026 | Feb 11, 2026 | -$0.36 | -$0.36 | +0.0% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$1.50 | -$1.38 | +8.0% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.89 | -$1.07 | -20.9% | — | — | — |
| ▲ Q2 FY2025 | May 29, 2025 | -$1.24 | -$0.74 | +40.3% | $0.00B | — | — |
| ▲ Q1 FY2025 | Feb 13, 2025 | -$2.40 | -$1.46 | +39.2% | — | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$2.47 | — | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.30
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 4, 2026
EPS Actual
-$0.23
EPS Est.
-$0.23
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2026
Feb 11, 2026
EPS Actual
-$0.36
EPS Est.
-$0.36
EPS Surpr.
+0.0%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$1.38
EPS Est.
-$1.50
EPS Surpr.
+8.0%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$1.07
EPS Est.
-$0.89
EPS Surpr.
-20.9%
Revenue
—
Q2 FY2025
May 29, 2025Beat
EPS Actual
-$0.74
EPS Est.
-$1.24
EPS Surpr.
+40.3%
Revenue
$0.00B
Q1 FY2025
Feb 13, 2025Beat
EPS Actual
-$1.46
EPS Est.
-$2.40
EPS Surpr.
+39.2%
Revenue
—
Q4 FY2024
Nov 8, 2024
EPS Actual
-$2.47
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2030 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q2 FY2030 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q1 FY2030 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q4 FY2029 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q3 FY2029 | $-0.17 | $-0.17 | $-0.17 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Jun 4, 2026 | +0.0% | $0.39 | $0.41 | +3.57% |
| ▲ Q1 FY2026 | Feb 11, 2026 | +0.0% | $0.42 | $0.39 | -6.84% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +8.0% | $0.85 | $0.85 | -0.18% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -20.9% | $1.14 | $1.11 | -2.63% |
| ▲ Q2 FY2025 | May 29, 2025 | +40.3% | $1.70 | $1.67 | -1.76% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +39.2% | $2.72 | $2.85 | +4.78% |
| — Q4 FY2024 | Nov 8, 2024 | — | $11.82 | $11.18 | -5.41% |
| — Q3 FY2024 | Aug 13, 2024 | — | $12.61 | $12.84 | +1.82% |
Q2 FY2026+3.57%
Report Date
Jun 4, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.39
Price After
$0.41
Q1 FY2026-6.84%
Report Date
Feb 11, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.42
Price After
$0.39
Q4 FY2025-0.18%
Report Date
Nov 12, 2025
EPS Beat/Miss
+8.0%
Price Before
$0.85
Price After
$0.85
Q3 FY2025-2.63%
Report Date
Aug 13, 2025
EPS Beat/Miss
-20.9%
Price Before
$1.14
Price After
$1.11
Q2 FY2025-1.76%
Report Date
May 29, 2025
EPS Beat/Miss
+40.3%
Price Before
$1.70
Price After
$1.67
Q1 FY2025+4.78%
Report Date
Feb 13, 2025
EPS Beat/Miss
+39.2%
Price Before
$2.72
Price After
$2.85
Q4 FY2024-5.41%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$11.82
Price After
$11.18
Q3 FY2024+1.82%
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$12.61
Price After
$12.84
Avg Beat Reaction-0.09%
Avg Miss Reaction-2.63%
Beat Rate5 / 8 quarters
Largest Move-6.84% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AMIX ends December
Autonomix Medical, Inc. Common Stock (AMIX) most recently reported earnings on June 4, 2026 for Q2 FY2026, posting EPS of $-0.23 (in line with the analyst consensus of $-0.23). AMIX has beaten EPS estimates for 3 consecutive quarters. The next AMIX earnings date is expected around September 1, 2026.
Each quarter, investors track AMIX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMIX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AMIX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AMIX earnings · 4 questionsAutonomix Medical, Inc. Common Stock's next earnings report is expected around September 1, 2026. AMIX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMIX historically reports after market close (AMC).
AMIX earnings datewhen is AMIX earningsAMIX next earnings datewhen does AMIX report earningsAMIX earnings calendar
▸ Source: FMP · Autonomix Medical, Inc. Common Stock SEC filings · US GAAP · Autonomix Medical, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026